Alexandra Rucavado Selected Research

Alexandra Rucavado Research Topics

Disease

30	Hemorrhage 03/2022 - 04/2002
14	Snake Bites (Snake Bite) 07/2022 - 10/2003
11	Edema (Dropsy) 07/2021 - 04/2002
6	Thrombocytopenia (Thrombopenia) 07/2022 - 10/2003
4	Inflammation (Inflammations) 03/2022 - 01/2020
4	Wounds and Injuries (Trauma) 10/2020 - 11/2009
3	Necrosis 03/2021 - 01/2011
3	Myotoxicity 01/2018 - 10/2008
3	Thrombosis (Thrombus) 03/2013 - 10/2003
2	Shock 10/2020 - 12/2009
2	Blister (Bulla) 01/2019 - 10/2008
2	Hemolysis 10/2017 - 03/2007
2	Hypovolemia 01/2015 - 12/2009
2	Rupture 01/2006 - 02/2005
1	Disseminated Intravascular Coagulation 07/2022
1	Brucellosis (Malta Fever) 03/2022
1	Acute Lung Injury 07/2021
1	Joint Diseases (Joint Disease) 01/2020
1	Atrophy 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Bites and Stings (Sting) 06/2017
1	Infections 01/2016
1	Melanoma (Melanoma, Malignant) 12/2014
1	Fibrosis (Cirrhosis) 01/2011
1	Bacterial Infections (Bacterial Infection) 12/2009
1	Ischemia 12/2009
1	Sudden Death 10/2003

Drug/Important Bio-Agent (IBA)

28	VenomsIBA 07/2022 - 10/2003
22	Metalloproteases (Metalloproteinases)IBA 07/2021 - 10/2003
16	Snake Venoms (Snake Venom)IBA 07/2021 - 11/2003
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 10/2008
5	Antivenins (Antivenoms)IBA 01/2021 - 01/2007
5	batimastat (BB 94)IBA 06/2017 - 04/2002
4	EnzymesIBA 07/2021 - 10/2003
4	Collagen Type IV (Type IV Collagen)IBA 03/2021 - 10/2008
4	Laminin (Merosin)IBA 03/2021 - 10/2008
4	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 11/2003
3	Extracellular Matrix ProteinsIBA 12/2014 - 11/2009
3	estropipate (Ogen)FDA LinkGeneric 03/2013 - 07/2005
2	aspercetinIBA 03/2022 - 07/2005
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 04/2002
2	Phospholipases A2 (Phospholipase A2)IBA 06/2018 - 11/2009
2	CoagulantsIBA 10/2016 - 10/2008
2	Fibronectins (Fibronectin)IBA 12/2014 - 11/2009
2	AntibodiesIBA 12/2009 - 03/2007
2	Phospholipases (Phospholipase)IBA 11/2009 - 10/2008
2	Bothrops jararaca VenomIBA 07/2005 - 11/2003
2	PeptidomimeticsIBA 03/2004 - 04/2002
1	CytokinesIBA 03/2022
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2021
1	Pentoxifylline (Trental)FDA LinkGeneric 07/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	ProteomeIBA 01/2019
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 10/2017
1	perlecanIBA 04/2016
1	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 04/2015
1	Collagen Type VIIBA 04/2015
1	nidogen (entactin)IBA 04/2015
1	DisintegrinsIBA 12/2014
1	VitronectinIBA 12/2014
1	Collagen Type I (Type I Collagen)IBA 12/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2013
1	Toxic ActionsIBA 09/2013
1	glycolic acid (glycolate)IBA 09/2013
1	Fibrinogen (Factor I)FDA Link 03/2013
1	FibrinIBA 03/2013
1	Serine Proteases (Serine Protease)IBA 03/2013
1	fibrin fragment D (D-dimer)IBA 03/2013
1	ZincIBA 07/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	Hemostatics (Antihemorrhagics)IBA 12/2009
1	C-Type Lectins (C-Type Lectin)IBA 12/2009
1	Synthetic DrugsIBA 12/2009
1	Non-Fibrillar CollagensIBA 11/2009
1	ApolipoproteinsIBA 11/2009
1	Apolipoproteins AIBA 11/2009
1	Fibrillar CollagensIBA 11/2009
1	Doxycycline (Periostat)FDA LinkGeneric 12/2008
1	Clodronic Acid (Clodronate)IBA 12/2008
1	Pharmaceutical PreparationsIBA 12/2008
1	Saline SolutionIBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	Blood Proteins (Serum Proteins)IBA 11/2003
1	Prothrombin (Factor II)IBA 10/2003
1	Metallothionein 3IBA 04/2002
1	Matrix Metalloproteinase InhibitorsIBA 04/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2007
3	Intravenous Administration 07/2005 - 10/2003
2	Intravenous Injections 07/2021 - 07/2005